EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, EGRX: Eagle Pharmaceuticals Inc

26 Nov 2025
LAST:

0.5000

CHANGE:
 0.15		OPEN:
0.6500		HIGH:
1.5250		ASK:
0.0000		VOLUME:
36.9K
CHG(%):
23.08		PREV:
0.6500		LOW:
0.3500		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
26 Nov 250.65001.52500.35000.500036.9K
25 Nov 250.60000.65000.60000.65002.0K
24 Nov 250.78000.78000.78000.7800800
21 Nov 250.78000.78000.78000.7800200
18 Nov 250.10041.80000.10040.7800900
17 Nov 251.25001.25001.25001.25001.1K
12 Nov 250.80001.30000.80001.3000500
07 Nov 250.25001.50000.25001.50001.5K

PROFILE

Name:Eagle Pharmaceuticals Inc
About:Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Sector:Healthcare
Address:50 Tice Boulevard, Woodcliff Lake, NJ, United States, 07677
Website:https://www.eagleus.com
CUSIP:269796108
CIK:0000827871
ISIN:US2697961082
FIGI:BBG005Y3XWH9
LEI:549300TN20OLYTJVP152

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:3.75 
Forward P/E:11.34 
Price to Sales:0.15 
Price to Book:0.16 
Revenue:257.55M 
EBITDA:62.33M 

TECHNICAL INDICATORS

MA5:0.7039.6%
MA10:0.9181.0%
MA20:0.9590.2%
MA50:2.34367.8%
MA100:2.24348.5%
MA200:1.61222.9%
RSI14:43.24
WPR14:-100.00 
MTM14:-0.20
ROC14:-0.29 
ATR:0.38 
Week High:1.53205.0%
Week Low:0.3542.9%
Month High:1.80260.0%
Month Low:0.10222.9%